Medinutrix Acquisition Gives Neuraxpharm Gateway To Ireland
Irish Distribution Firm Provides Platform To Market Buccolam
Executive Summary
Neuraxpharm will gain a platform in Ireland after striking a deal to acquire local distribution specialist Medinutrix.
You may also be interested in...
Neuraxpharm CEO Confirms Expansion Into New Markets, Including US
In an exclusive interview with Generics Bulletin, Neuraxpharm CEO Jörg-Thomas Dierks reveals that the company plans to expand out of Europe into other markets by acquiring companies in regions such as the US.
Neuraxpharm Enters Japanese Market
Neuraxpharm has expanded its footprint outside of Europe with the launch of its first product in Japan, in the form of the Buccolam value-added midazolam product gained through a deal with Takeda.
Deal Watch: GSK Makes $85m Wager On Surface’s Preclinical NK Cell Therapy
Although SRF813 isn’t likely to reach the clinic until 2021, GSK likes cell therapy’s monotherapy and combination potential. Lilly bids $880m to acquire neurodegenerative cell therapy firm Prevail.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: